Page last updated: 2024-08-21

oxazoles and Hematologic Neoplasms

oxazoles has been researched along with Hematologic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dorr, RT; Landowski, TH; Samulitis, BK	1

Other Studies

1 other study(ies) available for oxazoles and Hematologic Neoplasms

Article	Year
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers. Investigational new drugs, 2013, Volume: 31, Issue:6 Topics: Animals; Antineoplastic Agents; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Hematologic Neoplasms; Humans; Male; Mice; Mice, SCID; Oxazoles; Prostatic Neoplasms; Pyridines; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays	2013

Article

Year

The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers.

Investigational new drugs, 2013, Volume: 31, Issue:6

Topics: Animals; Antineoplastic Agents; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Hematologic Neoplasms; Humans; Male; Mice; Mice, SCID; Oxazoles; Prostatic Neoplasms; Pyridines; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays

2013